January 30, 2018
The Pharmaceutical Information Exchange Act, H.R. 2026, would ease current communication restrictions, permitting drug and medical device companies to discuss off-label information with health insurers. The bill recently passed out of Congress’ Energy and Commerce health subcommittee.
January 16, 2018
Cash-strapped states are exploring a controversial new way to cut Medicaid expenses: limiting which drugs their beneficiaries can access.
January 9, 2018
Winter weather blasted much of the nation last week, but it’s not just the common cold that Americans are fighting. Many regions, regardless of temperature, are also being pummeled by a different phenomenon – vaccine-preventable diseases.
December 14, 2017
As 2017 draws to a close, let’s take a look back at the highlights in patient access this year.
November 8, 2017
More than half of states in the U.S. are failing Medicaid patients with hepatitis C. A new report from the Harvard Law School and the National Viral Hepatitis Roundtable assigned 52 percent of states and U.S. territories a “D” or “F” for the access their Medicaid system provides to curative treatment for the disease.
October 30, 2017
“Man up” isn’t the advice you’d expect to hear at a policy summit on health care access for mothers and infants. But it’s just what Adam Busby, star of TLC’s “OutDaughtered” and keynote speaker at the third annual Infant Health Summit, felt during his struggle with postpartum depression.
October 25, 2017
The British Medical Journal ignited debate earlier this month when it announced that about half of cancer drugs approved by the European Medicines Agency don’t improve survival or quality of life. The claim begs several complex question: How can regulators evaluate drugs both quickly and effectively?
September 12, 2017
One in three U.S. drugs may have safety issues, explains a new Fast Facts policy brief from the Institute for Patient Access.
July 28, 2017
Most all of us know someone living in a long-term care facility – a friend, a former neighbor, a family member. But not all may be aware of a recent debate about the use of a certain type of medication – antipsychotic medication – for seniors living in these facilities.
July 17, 2017
Do coverage decisions aim to offer patients more treatment options – or drive patients to non-identical drugs based on cost alone?
